Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Allergan plc    AGN   IE00BY9D5467

ALLERGAN PLC

(AGN)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 04/02 02:53:19 pm
175.74 USD   +0.48%
12:40pABBVIE : Form 8.3 -
AQ
11:13aALLERGAN : Form 8.3 - -2-
DJ
11:13aALLERGAN : Form 8.3 -
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Allergan : Form 8.3 - -2-

share with twitter share with LinkedIn share with facebook
share via e-mail
03/26/2020 | 10:48am EDT
 (Note 8)                        (if applicable) (Note 5) 
---------------------  -------  ------------------------- 
N/A 
---------------------  -------  ------------------------- 
 
 
   4. OTHER INFORMATION 
 
   Agreements, arrangements or understandings relating to options or 
derivatives 
 
 
 
 
Full details of any agreement, arrangement or understanding 
 between the person disclosing and any other person 
 relating to the voting rights of any relevant securities 
 under any option referred to on this form or relating 
 to the voting rights or future acquisition or disposal 
 of any relevant securities to which any derivative 
 referred to on this form is referenced. If none, this 
 should be stated. 
----------------------------------------------------------- 
N/A 
----------------------------------------------------------- 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                     NO 
-------------------------------------------------------  ----------------- 
Date of disclosure                                       26(th) March 2020 
-------------------------------------------------------  ----------------- 
Contact name                                               Lionel Colaco 
-------------------------------------------------------  ----------------- 
Telephone number                                              020 33956098 
-------------------------------------------------------  ----------------- 
If a connected EFM, name of offeree/offeror with which   N/A 
 connected 
-------------------------------------------------------  ----------------- 
If a connected EFM, state nature of connection (Note     N/A 
 10) 
-------------------------------------------------------  ----------------- 
 
 
 
 
 
 

Stocks mentioned in the article
ChangeLast1st jan.
ABBVIE INC. 0.16% 73.77 Delayed Quote.-17.08%
ALLERGAN PLC 0.38% 175.74 Delayed Quote.-8.51%
This article is part of a news chaine.
Article 2 / 2
<< Preceding Next >>
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ALLERGAN PLC
12:40pABBVIE : Form 8.3 -
AQ
11:13aALLERGAN : Form 8.3 - -2-
DJ
11:13aALLERGAN : Form 8.3 -
DJ
11:08aDAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan Plc
DJ
07:31aALLERGAN : China Gives Greenlight to Allergan's XEN® Registration for the Surgic..
PR
04/01ALLERGAN : Form 8.3 - -2-
DJ
04/01ALLERGAN : Form 8.3 -
DJ
04/01ABBVIE : Form 8.3 -
AQ
04/01DAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan Plc
DJ
04/01DAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan plc
AQ
More news
Financials (USD)
Sales 2020 15 678 M
EBIT 2020 7 085 M
Net income 2020 192 M
Debt 2020 12 765 M
Yield 2020 1,70%
P/E ratio 2020 116x
P/E ratio 2021 43,1x
EV / Sales2020 4,48x
EV / Sales2021 4,06x
Capitalization 57 542 M
Chart ALLERGAN PLC
Duration : Period :
Allergan plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ALLERGAN PLC
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Average target price 193,50  $
Last Close Price 174,90  $
Spread / Highest target 45,8%
Spread / Average Target 10,6%
Spread / Lowest Target -10,2%
EPS Revisions
Managers
NameTitle
Brenton L. Saunders Chairman, President & Chief Executive Officer
Wayne R. Swanton Executive Vice President-Global Operations
Matthew M. Walsh Chief Financial Officer & Executive Vice President
C. David Nicholson Chief Research & Development Officer & EVP
Charles Hugh-Jones Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN PLC-8.51%58 266
JOHNSON & JOHNSON-10.10%345 705
ROCHE HOLDING AG1.53%277 060
MERCK & CO., INC-18.86%195 141
NOVARTIS-14.15%187 703
PFIZER, INC.-18.96%181 075